Enhabit, Inc.
$13.72
▲
0.21%
2026-04-21 06:35:01
www.ehab.com
NYQ: EHAB
Explore Enhabit, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$702.56 M
Current Price
$13.72
52W High / Low
$14.22 / $6.47
Stock P/E
—
Book Value
$10.53
Dividend Yield
—
ROCE
6.13%
ROE
-0.46%
Face Value
—
EPS
$-0.09
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Care Facilities
Employees
10,800
Beta
1.08
Debt / Equity
88.64
Current Ratio
1.63
Quick Ratio
1.63
Forward P/E
22.51
Price / Sales
0.67
Enterprise Value
$1.2 B
EV / EBITDA
13.85
EV / Revenue
1.13
Rating
Hold
Target Price
$13.8
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Auna SA | $5.52 | 14.63 | $415.95 M | — | 14.53% | 6.54% | $7.39 / $4.46 | $6.11 |
| 2. | AMN Healthcare Services, Inc. | $20.46 | — | $790.91 M | — | 2.19% | -14.19% | $23.74 / $14.87 | $16.7 |
| 3. | Charming Medical Limited | $29.36 | 441.53 | $497.21 M | — | 396.56% | -232.79% | $31.7 / $4.3 | $0 |
| 4. | Tenet Healthcare Corporation | $189.93 | 12.26 | $16.56 B | — | 13.64% | 27.02% | $247.21 / $109.82 | $48.53 |
| 5. | Pediatrix Medical Group, Inc. | $23.19 | 11.69 | $1.93 B | — | 12.93% | 20.28% | $24.99 / $11.84 | $10.68 |
| 6. | The Ensign Group, Inc. | $190 | 32.56 | $11.11 B | 0.13% | 9.31% | 16.89% | $218 / $118.73 | $38.71 |
| 7. | Option Care Health, Inc. | $28.77 | 21.68 | $4.5 B | — | 12.87% | 15.2% | $36.8 / $24.24 | $8.46 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 270.4 M | 263.6 M | 266.1 M | 259.9 M | 258.2 M | — |
| Operating Profit | 14.4 M | 16.8 M | 16.7 M | 15.9 M | 12.6 M | — |
| Net Profit | -38.7 M | 11.1 M | 5.2 M | 17.8 M | -46 M | — |
| EPS in Rs | -0.76 | 0.22 | 0.1 | 0.35 | -0.91 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 1.06 B | 1.03 B | 1.05 B | 1.07 B |
| Operating Profit | 63.8 M | 46.6 M | 38.2 M | 97.6 M |
| Net Profit | -4.6 M | -156.2 M | -80.5 M | -40.4 M |
| EPS in Rs | -0.09 | -3.08 | -1.59 | -0.8 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 1.17 B | 1.23 B | 1.43 B | 1.53 B |
| Total Liabilities | 603 M | 672.1 M | 731.9 M | 751.5 M |
| Equity | 534 M | 523.5 M | 669.7 M | 741.7 M |
| Current Assets | 205.6 M | 192.7 M | 210.1 M | 211.8 M |
| Current Liabilities | 126.3 M | 126.2 M | 137.7 M | 132.9 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 70.7 M | 51.2 M | 48.4 M | 80.1 M |
| Investing CF | 16.7 M | -2.4 M | -5.3 M | -42.3 M |
| Financing CF | -72.2 M | -48.3 M | -40.5 M | -18.6 M |
| Free CF | 65.8 M | 47.4 M | 44.9 M | 73 M |
| Capex | -4.9 M | -3.8 M | -3.5 M | -7.1 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -1.1% | -2.32% | — | — |
| Earnings Growth % | -94.04% | -99.26% | — | — |
| Profit Margin % | -15.09% | -7.69% | -3.77% | — |
| Operating Margin % | 4.5% | 3.65% | 9.11% | — |
| Gross Margin % | 48.71% | 48.81% | 50.93% | — |
| EBITDA Margin % | -8.08% | -1.58% | 2.1% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.